Latest news for Entest Group (OTC:ETNI) Stock

Entest Group Inc

<p><strong>Serve Robotics Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) shares are surging Monday potentially due to continued momentum from recent <a href="https://www.benzinga.com/news/24/07/39991694/whats-going-on-with-serve-robotics-shares-today">positive developments last week.</a></p>
<p><strong>What Happened</strong>: Serve Robotics recently closed a $15 million private placement with a single institutional investor. This includes the sale of pre-funded warrants for 2.5 million shares of common stock and additional warrants for up to 2.5 million shares at an exercise price of $6.00 per share. </p>
<p><strong>Key Developments</strong>: The company has also appointed finance leader <strong>David Goldberg </strong>to its Board of Directors and reappointed <strong>Sarfraz Maredia</strong>, an Uber Technologies executive, following their 2024 Annual Meeting of Stockholders. </p>
<p><strong>Stake and Volume</strong>: Serve Robotics shares have seen increased attention since <strong>NVIDIA Corp</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) reported a 10% stake in the company last week. This news has led to a <a href="https://www.benzinga.com/news/24/07/39972757/serve-robotics-stock-continues-to-soar-whats-going-on">500% increase in the stock since the NVIDIA filing.</a> The stock is also trending on social media platforms and experiencing higher than average trading volume, with 66.93 million shares traded compared to the 100-day average of 9.08 million.</p>
<p><strong>Background</strong>: Serve Robotics went public via a reverse merger with<strong> Patricia Acquisition Corp</strong>. Initially started as the robotics division of Postmates, Serve Robotics&#8217; autonomous sidewalk robots began delivering to Postmates customers in 2018. Following <strong>Uber Inc. &#8216;s </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) acquisition of Postmates in 2020, the robotics division was spun out as Serve Robotics.</p>
<p><strong>SERV Price Action: </strong>Serve Robotics shares were up by 30.3% at $17.23 at the time of writing, according to <a href="https://www.benzinga.com/pro/checkout/benzinga-pro-essential-2024?utm_source=BZprocontent072324&amp;t=be2bearmibe3na1">Benzinga Pro.</a></p>
<p><figure class="wp-block-image size-large is-resized"><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent072924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="533" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/29145237/SERV-1-1024x533.png" alt="" class="wp-image-463217" style="width:486px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/29145237/SERV-1-1024x533.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/29145237/SERV-1-300x156.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/29145237/SERV-1-768x400.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/29145237/SERV-1.png 1102w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure></p>
<p><strong>See Also:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/news/earnings/24/07/40013753/on-semiconductor-corp-beats-q2-earnings-and-revenue-estimates">ON Semiconductor Corp. Beats Q2 Earnings and Revenue Estimates</a></strong></li>
</ul>
<p><em>Image: Courtesy of Serve Robotics.</em></p>


News

Movers

NVDA

SERV

UBER

Serve Robotics Shares Are Trading Higher Today: What You Need To Know

<p>Financial giants have made a conspicuous bullish move on ConocoPhillips. Our analysis of options history for ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>) revealed 10 unusual trades.</p>
<p>Delving into the details, we found 50% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $244,371, and 4 were calls, valued at $203,869.</p>
<h3>What's The Price Target?</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $90.0 to $111.0 for ConocoPhillips during the past quarter. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in ConocoPhillips's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to ConocoPhillips's substantial trades, within a strike price spectrum from $90.0 to $111.0 over the preceding 30 days.</p>
<h3>ConocoPhillips Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1722280566_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>COP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$3.45</td>
<td>$3.4</td>
<td>$3.45</td>
<td>$110.00</td>
<td>$84.5K</td>
<td>1.6K</td>
<td>745</td>
</tr>
<tr>
<td>COP</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$1.2</td>
<td>$1.09</td>
<td>$1.11</td>
<td>$100.00</td>
<td>$82.4K</td>
<td>1.5K</td>
<td>963</td>
</tr>
<tr>
<td>COP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$3.4</td>
<td>$3.35</td>
<td>$3.4</td>
<td>$110.00</td>
<td>$57.1K</td>
<td>1.6K</td>
<td>1.3K</td>
</tr>
<tr>
<td>COP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$1.54</td>
<td>$1.53</td>
<td>$1.53</td>
<td>$95.00</td>
<td>$40.1K</td>
<td>206</td>
<td>262</td>
</tr>
<tr>
<td>COP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/09/24</td>
<td>$3.75</td>
<td>$3.05</td>
<td>$3.5</td>
<td>$111.00</td>
<td>$37.1K</td>
<td>41</td>
<td>117</td>
</tr>
</tbody>
</table>
</p>
<h3>About ConocoPhillips</h3>
<p>ConocoPhillips is a US-based independent exploration and production firm. In 2023, it produced 1.2 million barrels per day of oil and natural gas liquids and 3.1 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2023 were 6.8 billion barrels of oil equivalent.</p>
<h3>Where Is ConocoPhillips Standing Right Now?</h3>
<ul>
<li>With a volume of 2,614,164, the price of COP is down -1.89% at $108.76. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 3 days.</li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for ConocoPhillips, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Markets

ConocoPhillips's Options: A Look at What the Big Money is Thinking

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>Las Vegas Sands</strong>.</p>
<p>Looking at options history for Las Vegas Sands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVS#NYSE">LVS</a>) we detected 10 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 50% with bearish.</p>
<p>From the overall spotted trades, 7 are puts, for a total amount of $410,906 and 3, calls, for a total amount of $83,254.</p>
<h3>Projected Price Targets</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $32.5 and $45.0 for Las Vegas Sands, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Las Vegas Sands's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Las Vegas Sands's whale activity within a strike price range from $32.5 to $45.0 in the last 30 days. </p>
<h3>Las Vegas Sands Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1722280561_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>LVS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$3.2</td>
<td>$3.05</td>
<td>$3.05</td>
<td>$37.50</td>
<td>$122.0K</td>
<td>68</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>LVS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$4.25</td>
<td>$3.35</td>
<td>$4.1</td>
<td>$32.50</td>
<td>$61.5K</td>
<td>5</td>
<td style="text-align: right;">150</td>
</tr>
<tr>
<td>LVS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/20/24</td>
<td>$5.6</td>
<td>$5.55</td>
<td>$5.6</td>
<td>$45.00</td>
<td>$50.3K</td>
<td>2.4K</td>
<td style="text-align: right;">181</td>
</tr>
<tr>
<td>LVS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/20/24</td>
<td>$5.6</td>
<td>$5.55</td>
<td>$5.6</td>
<td>$45.00</td>
<td>$50.3K</td>
<td>2.4K</td>
<td style="text-align: right;">91</td>
</tr>
<tr>
<td>LVS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$5.65</td>
<td>$5.45</td>
<td>$5.48</td>
<td>$45.00</td>
<td>$44.8K</td>
<td>2.4K</td>
<td style="text-align: right;">287</td>
</tr>
</tbody>
</table>
</p>
<h3>About Las Vegas Sands</h3>
<p>Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore toward the end of 2028. Its Venetian and Palazzo Las Vegas assets in the U.S. were sold to Apollo and VICI in 2022. With the sale of its Vegas assets, the company generates all its EBITDA from Asia, with its casino operations generating the majority of sales.</p>
<p>In light of the recent options history for Las Vegas Sands, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Present Market Standing of Las Vegas Sands</h3>
<ul>
<li>Trading volume stands at 4,513,216, with LVS's price up by 1.35%, positioned at $39.71.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 79 days.</li>
</ul>
<h3>Professional Analyst Ratings for Las Vegas Sands</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $55.6.</p>
<ul>
<li>Maintaining their stance, an analyst from Susquehanna continues to hold a Positive rating for Las Vegas Sands, targeting a price of $51. </li>
<li>An analyst from Morgan Stanley persists with their Overweight rating on Las Vegas Sands, maintaining a target price of $55. </li>
<li>Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on Las Vegas Sands with a target price of $53. </li>
<li>An analyst from Wells Fargo persists with their Overweight rating on Las Vegas Sands, maintaining a target price of $58. </li>
<li>An analyst from Deutsche Bank has decided to maintain their Buy rating on Las Vegas Sands, which currently sits at a price target of $61. </li>
</ul>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Las Vegas Sands options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Las Vegas Sands Unusual Options Activity

<p>High-rolling investors have positioned themselves bullish on Sprouts Farmers Market (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>), and it's important for retail traders to take note.<br />
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in SFM often signals that someone has privileged information.</p>
<p>Today, Benzinga's options scanner spotted 8 options trades for Sprouts Farmers Market. This is not a typical pattern.</p>
<p>The sentiment among these major traders is split, with 62% bullish and 25% bearish. Among all the options we identified, there was one put, amounting to $25,500, and 7 calls, totaling $275,546.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $80.0 to $95.0 for Sprouts Farmers Market over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Sprouts Farmers Market's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Sprouts Farmers Market's substantial trades, within a strike price spectrum from $80.0 to $95.0 over the preceding 30 days.</p>
<h3>Sprouts Farmers Market Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1722280556_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>SFM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>09/20/24</td>
<td>$7.1</td>
<td>$7.0</td>
<td>$7.0</td>
<td>$85.00</td>
<td>$72.8K</td>
<td>171</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>SFM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/16/24</td>
<td>$5.1</td>
<td>$4.9</td>
<td>$5.0</td>
<td>$85.00</td>
<td>$49.5K</td>
<td>1.4K</td>
<td style="text-align: right;">211</td>
</tr>
<tr>
<td>SFM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/16/24</td>
<td>$2.1</td>
<td>$2.0</td>
<td>$2.08</td>
<td>$95.00</td>
<td>$41.6K</td>
<td>362</td>
<td style="text-align: right;">309</td>
</tr>
<tr>
<td>SFM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/16/24</td>
<td>$2.9</td>
<td>$2.7</td>
<td>$2.88</td>
<td>$90.00</td>
<td>$28.7K</td>
<td>1.6K</td>
<td style="text-align: right;">357</td>
</tr>
<tr>
<td>SFM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/16/24</td>
<td>$2.9</td>
<td>$2.7</td>
<td>$2.85</td>
<td>$90.00</td>
<td>$28.5K</td>
<td>1.6K</td>
<td style="text-align: right;">457</td>
</tr>
</tbody>
</table>
</p>
<h3>About Sprouts Farmers Market</h3>
<p>Sprouts Farmers Market Inc offers a unique specialty grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspire wellness naturally with a carefully curated assortment of better-for-you products paired with purpose-driven people. The company continues to bring the latest in wholesome, innovative products made with lifestyle-friendly ingredients such as organic, plant-based, and gluten-free. It approximately has 407 stores in 23 states. It is one of the largest and fastest-growing specialty retailers of fresh, natural and organic food in the United States.</p>
<p>In light of the recent options history for Sprouts Farmers Market, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Present Market Standing of Sprouts Farmers Market</h3>
<ul>
<li>Currently trading with a volume of 1,257,005, the SFM's price is down by -2.51%, now at $84.52. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 0 days.</li>
</ul>
<h3>Professional Analyst Ratings for Sprouts Farmers Market</h3>
<p>A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $80.5.</p>
<ul>
<li>An analyst from Evercore ISI Group has decided to maintain their In-Line rating on Sprouts Farmers Market, which currently sits at a price target of $77. </li>
<li>Maintaining their stance, an analyst from Goldman Sachs continues to hold a Buy rating for Sprouts Farmers Market, targeting a price of $89. </li>
<li>Consistent in their evaluation, an analyst from Deutsche Bank keeps a Hold rating on Sprouts Farmers Market with a target price of $76. </li>
<li>Maintaining their stance, an analyst from Evercore ISI Group continues to hold a In-Line rating for Sprouts Farmers Market, targeting a price of $80. </li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Sprouts Farmers Market, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Sprouts Farmers Market Unusual Options Activity For July 29

<p><strong>Mumu The Bull </strong>(CRYPTO: MUMU), a meme coin on <strong>Solana</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) is racing towards the <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39979140/dogecoin-killer-shiba-inu-sees-76-surge-in-q2-orders-on-crypto-payments-platform-coingate">top 100 cryptos</a> off the back of exchange listings and rising volume and liquidity.</p>
<p><strong>What Happened: </strong>Crypto trader Lucky noted the bull market's mascot is making "impressive strides in the crypto market." He adds that how the two-month-old project has raced to the 237<sup>th</sup> rank with a valuation of $250 million, attributing the success to the team&#8217;s dedication and the overwhelming community support. With exchange listings and a continuous influx of big players, Lucky <a href="https://x.com/LLuciano_BTC/status/1817915304087060677">predicts</a> it will not be surprising if MUMU breaks into the top 100 rankings in the future.</p>
<p>Another crypto trader <a href="https://x.com/The__Solstice/status/1817760647569871318">tweeted</a> that Mumu would be the most important meme coin in this cycle. He forecasts <strong>Shiba Inu</strong>&#8216;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) all-time high of $46 billion to &#8216;get smahed.&#8217;</p>
<p><strong>Trading Axe</strong> <a href="https://x.com/trading_axe/status/1817841513705169220">calls</a> Mumu the &#8220;highest beta animal coin.&#8221; Another trader sees Mumu still having exponential upside.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr">So you sold your <a href="https://twitter.com/search?q=%24MUMU&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$MUMU</a> yesterday to swap for <a href="https://twitter.com/search?q=%24NEIRO&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$NEIRO</a>? I told you to stop round tripping, rotating, and top selling&#8230;&#8230;. Don`t fade <a href="https://twitter.com/search?q=%24MUMU&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$MUMU</a>, we are going to do a solid 100X here with volume, liquidity and huge upcoming listings. Stick to the S-tier&#8230;&#8230; <a href="https://t.co/IqssE6N5sk">pic.twitter.com/IqssE6N5sk</a></p>
<p>&mdash; CoinCommander (@CoinCommanderX) <a href="https://twitter.com/CoinCommanderX/status/1817792721140199588?ref_src=twsrc%5Etfw">July 29, 2024</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p><strong>Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/40017189/dogecoin-owners-new-dog-neiro-gets-memed-developer-turns-3-sol-into-2-85m-in-suspected-fou">Dogecoin Owner&#8217;s New Dog Neiro Gets Memed, Developer Turns 3 SOL Into $2.85M In Suspected Foul Play</a></strong></p>
<p><strong>Why It Matters: </strong>Mumu The Bull is considered the mascot of the bull market and currently trading around a valuation of $232.6 million. The meme coin was created only in March this year.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr">The writing is on the wall <a href="https://twitter.com/search?q=%24MUMU&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$MUMU</a> <a href="https://t.co/N5uJyn0jJY">pic.twitter.com/N5uJyn0jJY</a></p>
<p>&mdash; MUMU THE BULL (@mumu_bull) <a href="https://twitter.com/mumu_bull/status/1817938653231960229?ref_src=twsrc%5Etfw">July 29, 2024</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p>In the past 24 hours, MUMU is up 27%, bringing its seven-day gains to over 120%. The meme coin will be <a href="https://x.com/BingXOfficial/status/1817848065560059941">listed</a> on BingX for spot trading shortly.</p>
<p>Crypto trader <strong>Kakashi </strong><a href="https://x.com/kkashi_yt/status/1817919383710425525">discovered</a> a trader who swapped 1 million WIF, worth $2.2 million, for MUMU. The trader has already recovered an initial loss of $1 million and is currently breaking even on his trade.</p>
<p><strong>What&#8217;s Next</strong>: The influence of meme coins and <a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a> is expected to be thoroughly explored at Benzinga&#8217;s upcoming <a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a> event on Nov. 19.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39990496/solanas-celebrity-meme-coins-down-94-on-average-initial-pump-and-then-nothing-researcher-n">Solana&#8217;s Celebrity Meme Coins Down 94% On Average: &#8216;Initial Pump And Then Nothing,&#8217; Researcher Notes</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$SHIB

$SOL

Mumu The Bull Meme Coin Up Over 120% In A Week, Will 'Smash' Shiba Inu Highs, Touta Trader

<p><strong>Windtree Therapeutics Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) shares are trading lower by 6.2% to $7.77 <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/40018649/wall-street-rises-ahead-of-big-tech-earnings-fed-meeting-tesla-rebounds-oil-prices-drop-to">during Monday&#8217;s session</a> after the company announced it entered a $1M private placement of Series C Convertible Preferred shares and Warrants.</p>
<p>The company <a href="https://ir.windtreetx.com/static-files/ffb4b126-75a8-4c42-8c00-6c53d421d608">says</a> the funds will be used for working capital and general corporate purposes. The deal is expected to close on July 29, pending customary conditions. The company will seek stockholder approval for the conversion of the Preferred Shares and the exercise of the Warrants into common stock.</p>
<p>During a restricted period, Windtree will not issue any new equity securities without the consent of major security holders. The agreement also includes a participation right for the buyer in future equity placements. The Warrants have an exercise price of $4.11 per share and will become exercisable six months after issuance, expiring five years later.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/news/24/07/40018005/why-micron-mu-stock-is-volatile-this-month">Why Micron Stock Is Volatile This Month</a></strong></p>
<h2 class="wp-block-heading">Should I Sell My WINT Stock?</h2>
<p>When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.</p>
<p>Shares of Windtree Therapeutics have decreased by 70.02% in the past year. An investor who bought shares of Windtree Therapeutics at the beginning of the year would take a loss of $5.07 per share if they sold it today. The stock has risen 134.37% over the past month, meaning an investor who bought shares on Jun. 1 would see a capital gain of $4.0.</p>
<p>For access to advanced charting and analysis tools and stock data, check out <a href="https://pro.benzinga.com/">Benzinga PRO. Try it for free.</a></p>
<p>WINT has a 52-week high of $29.88 and a 52-week low of $2.81.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/40018935/trumps-bitcoin-conference-pledge-can-he-really-fire-sec-chair-gensler"><strong>Trump&#8217;s Bitcoin Conference Pledge: Can He Really Fire SEC Chair Gensler?</strong></a></li>
</ul>
<p><em>Image created using artificial intelligence via Midjourney.</em></p>


WINT

Why Windtree Therapeutics (WINT) Stock Is Volatile Today

Federal Reserve

US Cuts July-Sept. Borrowing Estimate To $740B From $847B

<p><strong>Delta Air Lines, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) shares are down 1.9% to $43.26 Monday afternoon, marking a 7.6% decrease for July. The stock was volatile last week, initially falling but bouncing back following <a href="https://www.benzinga.com/news/earnings/24/07/39960297/american-airlines-q2-earnings-mixed-performance-amid-cost-pressures-lowers-annual-profit-outlook">financial reports</a> from <strong>American Airlines Group Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) and <strong>Southwest Airlines Co</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>).</p>
<p>Delta is additionally dealing with <a href="https://www.benzinga.com/government/24/07/39936988/delta-air-lines-faces-500m-financial-hit-as-it-outage-causes-thousands-of-cancellations">financial difficulties</a> due to a recent system failure that caused thousands of flight cancellations and prompted a federal investigation. Citigroup has cut Delta&#8217;s third-quarter earnings estimate by 60 cents per share to $1.37. Analysts predict a $350 million hit to operating profit and potential fines.</p>
<h2 class="wp-block-heading"><strong>Industry Impact</strong></h2>
<p>When major airlines like American Airlines and Southwest Airlines report worse-than-expected results, it suggests broader issues in the industry. Investors might believe Delta faces similar problems, such as rising operating costs, capacity management challenges and fluctuating demand.</p>
<p>Southwest Airlines reported a significant 13% increase in operating expenses, driven by higher salaries, wages, benefits, and maintenance costs. These pressures are likely affecting all airlines, including Delta, raising investor concerns about Delta's cost management and profitability.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/40018956/tesla-analyst-says-full-self-driving-matters-more-than-anything-else-latest-version">Tesla Analyst Says Full Self-Driving &#8216;Matters More Than Anything Else,&#8217; Latest Version Is &#8216;Revolutionary,&#8217; Will Take Stock To $300</a></strong></p>
<h2 class="wp-block-heading">How To Buy DAL Stock</h2>
<p>By now you're likely curious about how to participate in the market for Delta Air Lines &#8211; be it to purchase shares, or even attempt to bet against the company.</p>
<p>Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so. </p>
<p>In the case of Delta Air Lines, which is trading at $43.33 as of publishing time, $100 would buy you 2.31 shares of stock.</p>
<p>If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.</p>
<p>According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, DAL has a 52-week high of $53.86 and a 52-week low of $30.60.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/40016926/markets-brace-for-crucial-interest-rate-shake-up-what-to-expect-from-federal-reserv"><strong>Markets Brace For Crucial Interest Rate Shake-Up: What To Expect From Federal Reserve, Bank of Japan, Bank Of England This Week</strong></a></li>
</ul>


What's Going On With Delta Air Lines (DAL) Shares?

<p>Last week was a bumpy ride for tech stocks as earnings from <strong>Alphabet Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) and <strong>Tesla, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) set off <a href="https://www.benzinga.com/news/24/07/40005002/tesla-ceo-elon-musk-gives-fresh-timeline-for-fsd-access-on-cybertruck-says-it-should-be-coming-out-i">a major sell-off </a>that sent chills down investors&#8217; spines.</p>
<p>Big Tech should calm any remaining jitters this week as other top players in the sector show how much they are investing in artificial intelligence in their quests for gold medals, an analyst says.</p>
<p>This week&#8217;s upcoming tech earnings will be &#8220;a major positive catalyst&#8221; for the sector, which should see stocks jump another 15% to 20% for the year,<strong> Wedbush</strong> analyst <strong>Daniel Ives</strong> said.</p>
<p>&#8220;Now the broader tech growth story takes center stage with Big Tech names taking the torch this week aiming for a gold medal with all the Street watching,&#8221; he wrote in a note on Monday.</p>
<p>Investors will be paying close attention to earnings, he said, from fellow behemoths <strong>Microsoft Corp </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), <strong>Amazon Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) <strong>Meta Platforms, Inc.</strong> NASDAQ: META), <strong>Apple Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and others for any cues on capital expenditure and consumer spending trends in the AI space that clearly show that making money off AI will boost Wall Street numbers to the end of 2025.</p>
<p>&#8220;We believe the tech sell-off seen last week will be short-lived as the Street better digests results and commentary from the broader tech sector over the coming weeks during 2Q earnings season,&#8221; he wrote in a note.</p>
<p>&#8220;This is the start &#8230; not the end of this tech bull run we expect the next few years.&#8221;</p>
<p>Microsoft is scheduled to report fiscal fourth-quarter earnings on Tuesday, while Meta plans to post its fiscal second-quarter earnings on Wednesday. On Thursday, Amazon is set to release its second-quarter results and Apple is expected to reveal its earnings for its fiscal third quarter.</p>
<p><strong>Read Also:</strong> <strong><a href="https://www.benzinga.com/news/24/07/39845906/whats-going-on-with-googles-parent-alphabet-stock-on-thursday">What&#8217;s Going On With Google&#8217;s Parent Alphabet Stock On Thursday?</a></strong></p>
<p>&#8220;We estimate that companies, utilities, governments will spend over $1 trillion combined in AI capex over the coming years fueling this AI Revolution,&#8221; Ives wrote.</p>
<p>&#8220;Alphabet is accelerating its spending on the AI cycle and we expect similar comments from Big Tech stalwarts this week.&#8221;</p>
<p>He said investors may be worried about the &#8220;massive spending wave&#8221; and frustrated that it will take time for AI investments by these tech giants to show up in quarterly results, but patience will be needed on the coming AI payback.</p>
<p>&#8220;We strongly contrast this is not Meta/Zuckerberg spending on metaverse from 2 years ago, instead this is an AI arms race taking place in the U.S., China, and around the globe for building out the enterprise and consumer AI ecosystem,&#8221; he said. &#8220;Rome was not built in a day and neither will this unprecedented AI Revolution.&#8221;</p>
<p>Wedbush is therefore &#8220;focused on a multiyear bull tech run&#8221; while the Federal Reserve is expected to cut interest rates in a risk-on environment that will impact future derivatives of the AI revolution, Ives said.</p>
<p>That said, the Wedbush &#8220;playbook continues to be on the AI Revolution thesis and winners on sell-offs like we experienced last week,&#8221; he wrote.</p>
<p><strong>Price Action</strong>: Tech stocks were trending upward for the most part as Monday&#8217;s trading approached mid-day.</p>
<ul>
<li>Microsoft edged up 0.39% to $426.90</li>
<li>Amazon rose 0.24% to $182.94</li>
<li>Meta gained 0.17% to $466.86</li>
<li>Apple is up 0.21%  to $218.41</li>
<li>Tesla jumped 5.38% to $231.62</li>
<li>Alphabet went up 1.32% to $170.91</li>
</ul>
<p><strong>Read Now:</strong> </p>
<p><strong><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/40006542/apple-amazon-microsoft-meta-lead-the-charge-as-investors-bank-on-tech-cheer-for-ral">Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally&#8217;s Reacceleration: Week Ahead In Earnings</a></strong></p>
<p><em>Photo: <a href="https://pixabay.com/users/michalnavrat-6900665/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=3529744">Michal Navrat</a> from <a href="https://pixabay.com//?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=3529744">Pixabay</a></em></p>


Analyst Color

Earnings

Tech

AAPL

AMZN

GOOG

GOOGL

MSFT

TSLA

Big Tech Stocks Poised For 'Gold Medals' As They Ride AI Wave Into Earnings

<p>Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) has outperformed the market over the past 20 years by 3.65% on an annualized basis producing an average annual return of 12.06%. Currently, Gilead Sciences has a market capitalization of $96.59 billion. </p>
<p><strong>Buying $100 In GILD:</strong> If an investor had bought $100 of GILD stock 20 years ago, it would be worth <strong>$986.39</strong> today based on a price of $77.53 for GILD at the time of writing.</p>
<h3>Gilead Sciences's Performance Over Last 20 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1722279755_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Trading Ideas

GILD

$100 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today

<p>Over the past 24 hours, <strong>Bittensor's</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TAO</a>) price has fallen 3.05% to <strong>$328.38</strong>. This is opposite to its positive trend over the past week where it has experienced a 1.0% gain, moving from $327.46 to its current price. </p>
<p>The chart below compares the price movement and volatility for Bittensor over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1722279743_0.png" alt="price_chart" /></p>
<p>Bittensor's trading volume has climbed 5.0% over the past week, moving in tandem, directionally, with the overall circulating supply of the coin, which has increased 0.61%. This brings the circulating supply to 7.14 million, which makes up an estimated 34.02% of its max supply of 21.00 million. According to our data, the current market cap ranking for TAO is #47 at $2.35 billion.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1722279743_1.png" alt="supply_and_vol" /></p>
<p><a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


$TAO

Cryptocurrency Bittensor Falls More Than 3% In 24 hours

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Blackstone</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with BX, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 9 uncommon options trades for Blackstone.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 22% bullish and 55%, bearish.</p>
<p>Out of all of the special options we uncovered, 5 are puts, for a total amount of $1,455,349, and 4 are calls, for a total amount of $184,222.</p>
<h3>Expected Price Movements</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $100.0 to $155.0 for Blackstone during the past quarter. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Blackstone's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Blackstone's whale trades within a strike price range from $100.0 to $155.0 in the last 30 days. </p>
<h3>Blackstone Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1722279688_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th style="text-align: right;"><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$23.75</td>
<td>$21.2</td>
<td>$23.4</td>
<td>$150.00</td>
<td>$1.1M</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">500</td>
</tr>
<tr>
<td>BX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$8.0</td>
<td>$7.95</td>
<td>$7.95</td>
<td>$135.00</td>
<td>$141.5K</td>
<td style="text-align: right;">414</td>
<td style="text-align: right;">178</td>
</tr>
<tr>
<td>BX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/20/24</td>
<td>$43.4</td>
<td>$41.35</td>
<td>$42.17</td>
<td>$100.00</td>
<td>$88.5K</td>
<td style="text-align: right;">444</td>
<td style="text-align: right;">21</td>
</tr>
<tr>
<td>BX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$16.65</td>
<td>$15.65</td>
<td>$15.92</td>
<td>$155.00</td>
<td>$50.9K</td>
<td style="text-align: right;">246</td>
<td style="text-align: right;">65</td>
</tr>
<tr>
<td>BX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$12.2</td>
<td>$11.9</td>
<td>$12.08</td>
<td>$150.00</td>
<td>$49.5K</td>
<td style="text-align: right;">294</td>
<td style="text-align: right;">41</td>
</tr>
</tbody>
</table>
</p>
<h3>About Blackstone</h3>
<p>Blackstone is the world's largest alternative-asset manager with $1.040 trillion in total asset under management, including $762.6 billion in fee-earning assets under management, at the end of 2023. The company has four core business segments: private equity (22% of fee-earning AUM and 28% of base management fees), real estate (39% and 43%), credit and insurance (29% and 21%), and hedge fund solutions (10% and 8%). While the firm primarily serves institutional investors (87% of AUM), it also caters to clients in the high-net-worth channel (13%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).</p>
<p>After a thorough review of the options trading surrounding Blackstone, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Where Is Blackstone Standing Right Now?</h3>
<ul>
<li>With a volume of 1,289,544, the price of BX is up 0.09% at $141.31. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 80 days.</li>
</ul>
<h3>Expert Opinions on Blackstone</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $146.6.</p>
<ul>
<li>Maintaining their stance, an analyst from Piper Sandler continues to hold a Overweight rating for Blackstone, targeting a price of $149. </li>
<li>Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on Blackstone with a target price of $145. </li>
<li>An analyst from Morgan Stanley persists with their Overweight rating on Blackstone, maintaining a target price of $164. </li>
<li>An analyst from Barclays persists with their Equal-Weight rating on Blackstone, maintaining a target price of $141. </li>
<li>Maintaining their stance, an analyst from Piper Sandler continues to hold a Overweight rating for Blackstone, targeting a price of $134. </li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Blackstone, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Looking At Blackstone's Recent Unusual Options Activity

<p>Throughout the last three months, 4 analysts have evaluated Allison Transmission (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALSN#NYSE">ALSN</a>), offering a diverse set of opinions from bullish to bearish.</p>
<p>The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $81.75, a high estimate of $90.00, and a low estimate of $72.00. This upward trend is evident, with the current average reflecting a 9.0% increase from the previous average price target of $75.00.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1722279683_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>The perception of Allison Transmission by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jerry Revich</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Sell</td>
<td>$72.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Luke Junk</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$90.00</td>
<td>$87.00</td>
</tr>
<tr>
<td>Tim Thein</td>
<td>Raymond James</td>
<td>Announces</td>
<td>Outperform</td>
<td>$85.00</td>
<td>-</td>
</tr>
<tr>
<td>Kyle Menges</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Neutral</td>
<td>$80.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Allison Transmission. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Allison Transmission compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of Allison Transmission's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Capture valuable insights into Allison Transmission's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/ALSN/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Allison Transmission analyst ratings.</strong></a></p>
<h2>Discovering Allison Transmission: A Closer Look</h2>
<p>Allison Transmission is the largest manufacturer of fully automatic transmissions for commercial vehicles. The company's automatic transmissions allow customers to achieve better fuel and operator efficiency than less expensive manual and automated manual transmissions. Allison serves several end markets, including on- and off-highway equipment and military vehicles. Its on-highway business has about 60% global market share. The company's transmissions can be found in Class 4-8 trucks, buses, and a limited number of large passenger vehicles (heavy-duty pickup trucks and motor homes). Allison also produces electric hybrid propulsion systems and is developing e-powertrains.</p>
<h3>Financial Milestones: Allison Transmission's Journey</h3>
<p><strong>Market Capitalization Analysis:</strong> Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Allison Transmission's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of <strong>3.42%</strong>. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.</p>
<p><strong>Net Margin:</strong> Allison Transmission's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>22.92%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Allison Transmission's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>13.23%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Allison Transmission's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>3.66%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Allison Transmission's debt-to-equity ratio is notably higher than the industry average. With a ratio of <b>1.62</b>, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings

ALSN

What 4 Analyst Ratings Have To Say About Allison Transmission

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>Exxon Mobil</strong>.</p>
<p>Looking at options history for Exxon Mobil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) we detected 18 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 44% of the investors opened trades with bullish expectations and 55% with bearish.</p>
<p>From the overall spotted trades, 6 are puts, for a total amount of $276,530 and 12, calls, for a total amount of $546,757.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $95.0 to $130.0 for Exxon Mobil over the last 3 months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Exxon Mobil stands at 4455.29, with a total volume reaching 12,324.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Exxon Mobil, situated within the strike price corridor from $95.0 to $130.0, throughout the last 30 days.</p>
<h3>Exxon Mobil 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1722279683_0_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>XOM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/23/24</td>
<td>$2.71</td>
<td>$2.7</td>
<td>$2.71</td>
<td>$116.00</td>
<td>$114.0K</td>
<td>105</td>
<td style="text-align: right;">432</td>
</tr>
<tr>
<td>XOM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$3.5</td>
<td>$3.45</td>
<td>$3.45</td>
<td>$115.00</td>
<td>$69.0K</td>
<td>10.9K</td>
<td style="text-align: right;">279</td>
</tr>
<tr>
<td>XOM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$3.35</td>
<td>$3.3</td>
<td>$3.3</td>
<td>$115.00</td>
<td>$66.0K</td>
<td>10.9K</td>
<td style="text-align: right;">927</td>
</tr>
<tr>
<td>XOM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/18/26</td>
<td>$17.5</td>
<td>$16.75</td>
<td>$17.5</td>
<td>$115.00</td>
<td>$52.5K</td>
<td>2.4K</td>
<td style="text-align: right;">30</td>
</tr>
<tr>
<td>XOM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$1.91</td>
<td>$1.9</td>
<td>$1.91</td>
<td>$130.00</td>
<td>$48.7K</td>
<td>3.3K</td>
<td style="text-align: right;">265</td>
</tr>
</tbody>
</table>
</p>
<h3>About Exxon Mobil</h3>
<p>ExxonMobil is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2023, it produced 2.4 million barrels of liquids and 7.7 billion cubic feet of natural gas per day. At the end of 2023, reserves were 16.9 billion barrels of oil equivalent, 66% of which were liquids. The company is one the world's largest refiners with a total global refining capacity of 4.5 million barrels of oil per day and is one of the world's largest manufacturers of commodity and specialty chemicals.</p>
<p>Following our analysis of the options activities associated with Exxon Mobil, we pivot to a closer look at the company's own performance.</p>
<h3>Current Position of Exxon Mobil</h3>
<ul>
<li>With a trading volume of 5,055,839, the price of XOM is down by -0.97%, reaching $116.19.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 4 days from now.</li>
</ul>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Exxon Mobil with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Unpacking the Latest Options Trading Trends in Exxon Mobil

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Alibaba Gr Hldgs</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with BABA, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 49 uncommon options trades for Alibaba Gr Hldgs.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 63% bullish and 30%, bearish.</p>
<p>Out of all of the special options we uncovered, 19 are puts, for a total amount of $1,523,846, and 30 are calls, for a total amount of $1,782,695.</p>
<h3>What's The Price Target?</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $72.5 to $100.0 for Alibaba Gr Hldgs during the past quarter. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Alibaba Gr Hldgs's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Alibaba Gr Hldgs's substantial trades, within a strike price spectrum from $72.5 to $100.0 over the preceding 30 days.</p>
<h3>Alibaba Gr Hldgs 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1722279678_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BABA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$9.8</td>
<td>$9.8</td>
<td>$9.8</td>
<td>$75.00</td>
<td>$196.0K</td>
<td>2.0K</td>
<td>225</td>
</tr>
<tr>
<td>BABA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$23.25</td>
<td>$19.65</td>
<td>$21.0</td>
<td>$100.00</td>
<td>$161.7K</td>
<td>3</td>
<td>0</td>
</tr>
<tr>
<td>BABA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$7.5</td>
<td>$7.4</td>
<td>$7.4</td>
<td>$80.00</td>
<td>$148.0K</td>
<td>4.1K</td>
<td>288</td>
</tr>
<tr>
<td>BABA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$7.4</td>
<td>$7.3</td>
<td>$7.3</td>
<td>$80.00</td>
<td>$146.0K</td>
<td>4.1K</td>
<td>690</td>
</tr>
<tr>
<td>BABA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/02/24</td>
<td>$0.53</td>
<td>$0.47</td>
<td>$0.53</td>
<td>$81.00</td>
<td>$101.0K</td>
<td>2.0K</td>
<td>9.8K</td>
</tr>
</tbody>
</table>
</p>
<h3>About Alibaba Gr Hldgs</h3>
<p>Alibaba is the world's largest online and mobile commerce company as measured by gross merchandise volume. It operates China's online marketplaces, including Taobao (consumer-to-consumer) and Tmall (business-to-consumer). The China commerce retail division is the most valuable cash flow-generating business at Alibaba. Additional revenue sources include China commerce wholesale, international commerce retail/wholesale, local consumer services, cloud computing, digital media and entertainment platforms, Cainiao logistics services, and innovation initiatives/other.</p>
<p>Following our analysis of the options activities associated with Alibaba Gr Hldgs, we pivot to a closer look at the company's own performance.</p>
<h3>Alibaba Gr Hldgs's Current Market Status</h3>
<ul>
<li>With a trading volume of 13,269,702, the price of BABA is up by 2.64%, reaching $78.55.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 14 days from now.</li>
</ul>
<h3>What The Experts Say On Alibaba Gr Hldgs</h3>
<p>A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $116.0.</p>
<ul>
<li>An analyst from Jefferies persists with their Buy rating on Alibaba Gr Hldgs, maintaining a target price of $116. </li>
</ul>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Alibaba Gr Hldgs with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


BABA

What the Options Market Tells Us About Alibaba Gr Hldgs

<p><strong>Maker's</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/mkr/usd">MKR</a>) price has increased 3.92% over the past 24 hours to <strong>$2,768.31</strong>. Over the past week, MKR has experienced an uptick of over 1.0%, moving from $2,741.09 to its current price.  As it stands right now, <strong>the coin's all-time high is $6,292.31</strong>. </p>
<p>The chart below compares the price movement and volatility for Maker over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1722279674_0.png" alt="price_chart" /></p>
<p>The trading volume for the coin has fallen 32.0% over the past week, moving in tandem, directionally, with the overall circulating supply of the coin, which has decreased 0.18%. This brings the circulating supply to 930 thousand, which makes up an estimated 92.53% of its max supply of 1.01 million. According to our data, the current market cap ranking for MKR is #37 at $2.58 billion.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1722279674_1.png" alt="supply_and_vol" /></p>
<p><a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


$MKR

Cryptocurrency Maker Up More Than 3% In 24 hours

<p>In the latest quarter, 15 analysts provided ratings for Blueprint Medicines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPMC#NASDAQ">BPMC</a>), showcasing a mix of bullish and bearish perspectives.</p>
<p>The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $116.47, a high estimate of $168.00, and a low estimate of $75.00. This upward trend is apparent, with the current average reflecting a 18.93% increase from the previous average price target of $97.93.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1722279652_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>A comprehensive examination of how financial experts perceive Blueprint Medicines is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Peter Lawson</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$105.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Michael Ulz</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$115.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Matthew Biegler</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$125.00</td>
<td>$114.00</td>
</tr>
<tr>
<td>Ami Fadia</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$130.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Reni Benjamin</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$125.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Sudan Loganathan</td>
<td>Stephens &amp; Co.</td>
<td>Announces</td>
<td>Overweight</td>
<td>$140.00</td>
<td>-</td>
</tr>
<tr>
<td>Andrew Berens</td>
<td>Leerink Partners</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$97.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Terence Flynn</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$168.00</td>
<td>$121.00</td>
</tr>
<tr>
<td>David Lebowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Sell</td>
<td>$76.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Andrew Fein</td>
<td>HC Wainwright &amp; Co.</td>
<td>Raises</td>
<td>Buy</td>
<td>$135.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Reni Benjamin</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$125.00</td>
<td>$114.00</td>
</tr>
<tr>
<td>Peter Lawson</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$75.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Christopher Raymond</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$104.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Ami Fadia</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$130.00</td>
<td>$97.00</td>
</tr>
<tr>
<td>Ami Fadia</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$97.00</td>
<td>$97.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Blueprint Medicines. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Blueprint Medicines compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts predict movements in price targets, offering estimates for Blueprint Medicines's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>For valuable insights into Blueprint Medicines's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/BPMC/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Blueprint Medicines analyst ratings.</strong></a></p>
<h2>Unveiling the Story Behind Blueprint Medicines</h2>
<p>Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.</p>
<h3>Unraveling the Financial Story of Blueprint Medicines</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Blueprint Medicines's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>51.87%</strong> as of 31 March, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.</p>
<p><strong>Net Margin:</strong> Blueprint Medicines's net margin excels beyond industry benchmarks, reaching <strong>92.74%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Blueprint Medicines's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>40.4%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>8.54%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>1.06</strong>, Blueprint Medicines adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


BPMC

15 Analysts Have This To Say About Blueprint Medicines

<p>Mohawk Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHK#NYSE">MHK</a>) has been analyzed by 12 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets, analyzed by analysts, offer insights with an average target of $154.08, a high estimate of $185.00, and a low estimate of $118.00. This upward trend is evident, with the current average reflecting a 21.85% increase from the previous average price target of $126.45.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1722279644_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>The standing of Mohawk Industries among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Laura Champine</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Buy</td>
<td>$185.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Matthew Bouley</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$161.00</td>
<td>$118.00</td>
</tr>
<tr>
<td>Susan Maklari</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$185.00</td>
<td>$141.00</td>
</tr>
<tr>
<td>Michael Dahl</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$140.00</td>
<td>$108.00</td>
</tr>
<tr>
<td>Sam Reid</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Underweight</td>
<td>$140.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Keith Hughes</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$184.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Timothy Wojs</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$160.00</td>
<td>$132.00</td>
</tr>
<tr>
<td>Rafe Jadrosich</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$177.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Matthew Bouley</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$118.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Keith Hughes</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$135.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Sam Darkatsh</td>
<td>Raymond James</td>
<td>Announces</td>
<td>Strong Buy</td>
<td>$140.00</td>
<td>-</td>
</tr>
<tr>
<td>Michael Rehaut</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$124.00</td>
<td>$122.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Mohawk Industries. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Mohawk Industries compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of Mohawk Industries's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>For valuable insights into Mohawk Industries's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/MHK/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Mohawk Industries analyst ratings.</strong></a></p>
<h2>All You Need to Know About Mohawk Industries</h2>
<p>Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Geographically, it derives a majority of its revenue from the United States.</p>
<h3>Understanding the Numbers: Mohawk Industries's Finances</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Mohawk Industries's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>4.55%</strong> as of 30 June, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>5.62%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Mohawk Industries's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>2.06%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>1.17%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> Mohawk Industries's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.37</strong>.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Assessing Mohawk Industries: Insights From 12 Financial Analysts

<p>During the last three months, 5 analysts shared their evaluations of WisdomTree (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WT#NYSE">WT</a>), revealing diverse outlooks from bullish to bearish.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $12.9, a high estimate of $15.00, and a low estimate of $11.00. Surpassing the previous average price target of $11.40, the current average has increased by 13.16%.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1722279637_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>A clear picture of WisdomTree's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>George Sutton</td>
<td>Craig-Hallum</td>
<td>Raises</td>
<td>Buy</td>
<td>$15.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Mike Grondahl</td>
<td>Northland Capital Markets</td>
<td>Raises</td>
<td>Outperform</td>
<td>$13.50</td>
<td>$12.00</td>
</tr>
<tr>
<td>Aidan Hall</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$12.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Chris Kotowski</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$13.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$11.00</td>
<td>$10.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to WisdomTree. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of WisdomTree compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for WisdomTree's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of WisdomTree's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/WT/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on WisdomTree analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>Delving into WisdomTree's Background</h2>
<p>WisdomTree Inc is a financial innovator, offering a well-diversified suite of exchange-traded products (ETPs), models, and solutions. It offers a broad range of ETFs and exchange-traded products (ETPs). The firm also engages in developing next-generation digital products and structures, including digital funds and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime.</p>
<h3>Unraveling the Financial Story of WisdomTree</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> WisdomTree's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2024, the company achieved a revenue growth rate of approximately <strong>18.03%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.</p>
<p><strong>Net Margin:</strong> WisdomTree's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of <strong>20.64%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> WisdomTree's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>4.8%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>2.13%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.65</strong>.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


5 Analysts Have This To Say About WisdomTree

<p>Ratings for Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) were provided by 15 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>In the assessment of 12-month price targets, analysts unveil insights for Colgate-Palmolive, presenting an average target of $104.2, a high estimate of $112.00, and a low estimate of $91.00. Marking an increase of 6.49%, the current average surpasses the previous average price target of $97.85. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1722279629_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>The perception of Colgate-Palmolive by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Steve Powers</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$107.00</td>
<td>$104.00</td>
</tr>
<tr>
<td>Dara Mohsenian</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$111.00</td>
<td>$103.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$96.00</td>
<td>$91.00</td>
</tr>
<tr>
<td>Kaumil Gajrawala</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$95.00</td>
<td>$103.00</td>
</tr>
<tr>
<td>Robert Moskow</td>
<td>TD Cowen</td>
<td>Announces</td>
<td>Buy</td>
<td>$110.00</td>
<td>-</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$105.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$91.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Robert Ottenstein</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$106.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Steve Powers</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$104.00</td>
<td>$98.00</td>
</tr>
<tr>
<td>Filippo Falorni</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$112.00</td>
<td>$103.00</td>
</tr>
<tr>
<td>Bryan Spillane</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$110.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Chris Carey</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$97.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Kevin Grundy</td>
<td>Exane BNP Paribas</td>
<td>Announces</td>
<td>Outperform</td>
<td>$109.00</td>
<td>-</td>
</tr>
<tr>
<td>Dara Mohsenian</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$103.00</td>
<td>$101.00</td>
</tr>
<tr>
<td>Chris Graja</td>
<td>Argus Research</td>
<td>Raises</td>
<td>Buy</td>
<td>$107.00</td>
<td>$97.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Colgate-Palmolive. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Colgate-Palmolive compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Colgate-Palmolive's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Colgate-Palmolive's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CL/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Colgate-Palmolive analyst ratings.</strong></a></p>
<h2>Get to Know Colgate-Palmolive Better</h2>
<p>Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's, which primarily sells its products through veterinarians and specialty pet retailers.</p>
<h3>Colgate-Palmolive's Financial Performance</h3>
<p><strong>Market Capitalization Highlights:</strong> Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Colgate-Palmolive's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>6.18%</strong> as of 31 March, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Consumer Staples sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Colgate-Palmolive's net margin is impressive, surpassing industry averages. With a net margin of <strong>13.48%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Colgate-Palmolive's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>162.81%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Colgate-Palmolive's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>4.14%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> Colgate-Palmolive's debt-to-equity ratio surpasses industry norms, standing at <strong>37.78</strong>. This suggests the company carries a substantial amount of debt, posing potential financial challenges.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

Entest Group

News

Latest news for Entest Group (OTC:ETNI) Stock